Breast Cancer Detection Breakthrough Achieved by AI Tech Startup Raises Survival Rates by 20% in Clinical Trials
A Silicon Valley AI startup, InnoVue Health, has unveiled a revolutionary diagnostic tool that detects breast cancer up to three years earlier than traditional mammograms, cutting false positives by 40% and boosting patient survival odds. CEO Sarah Chen confirmed that early-stage trials show a 20% survival rate improvement, driving a 12% spike in company shares pre-market. "This isn't just a product; it's a mortality reduction play," Chen said. Analysts predict the technology will disrupt the $5 billion global screening market by 2026.